In addition, high expression of DCLK1 is associated with low CD8+ T cell infiltration [166], and one study has found that the use of DCLK1-IN-1 in renal cell carcinoma can promote the efficacy of ICIs [289], which provides new ideas for the treatment of CRC. Here, DCLK1 is linked to renal cell carcinoma.